Full-Time

Technologist

Mri

Confirmed live in the last 24 hours

Akumin

Akumin

201-500 employees

Outsourced radiology and oncology services provider

No salary listed

Entry, Junior

Raleigh, NC, USA

Local travel may be required. Residents living in CA, NY, Jersey City, NJ, WA and CO are directed to view pay range information.

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • High School Diploma or equivalent experience
  • Registered Technologist by the ARRT, NMTCB or ARMDS
  • MR registered technologist R.T. (MR) ARRT or ARMRIT
  • Technologist registered in other modalities
  • 3 months supervised MRI clinical scanning experience OR currently enrolled for more than 6 months in an accredited MRI training program
  • State license
  • Licensed Radiologic Technologist or Magnetic Resonance Technologist, if applicable
  • CPR Certification
  • BLS upon hire, ACLS within 90 days of employment, if applicable
  • Active State Driver’s License, required
  • The COVID-19 vaccination is/may be a condition of employment
  • All candidates who accept an offer for employment will be required to successfully complete a pre-employment background check and drug screen as a condition of employment
  • Local travel may be required.
Responsibilities
  • Responsible for Patient Safety, including pre-screening for contra-indications, aseptic injection technique and may require remote MR Technologists Assistant oversite.
  • Produces high quality diagnostic images. Operation of multiple MR systems may be required.
  • Demonstrates the ability to use all channels of communications to address concerns, solve problems, and address conflict.
  • Effectively communicates with customers and/or radiologists.
  • Trains and orients new technologists, patient coordinators and MR Technologist Assistants, on site and/or remote.
  • Other duties as assigned.
Desired Qualifications
  • Associate’s Degree or equivalent experience
  • 1 year of Magnetic Resonance Imaging Experience
  • Registry in Magnetic Resonance by the ARRT

Akumin provides outsourced radiology and oncology services to hospitals, health systems, and physician groups throughout the United States. Their offerings include fixed-site outpatient diagnostic imaging services, which are available at various imaging locations, as well as outpatient radiology and oncology services that support around 1,000 hospitals and health systems across 47 states. What sets Akumin apart from its competitors is its extensive network and ability to deliver comprehensive solutions tailored to the needs of healthcare providers. The company's goal is to enhance patient care by providing reliable and accessible imaging and oncology services.

Company Size

201-500

Company Stage

IPO

Headquarters

Plantation, Florida

Founded

1997

Simplify Jobs

Simplify's Take

What believers are saying

  • Financial restructuring with Stonepeak strengthens Akumin's balance sheet and liquidity.
  • Growing demand for outpatient imaging services supports Akumin's business model.
  • Partnerships with tech firms offer opportunities to integrate advanced imaging analytics.

What critics are saying

  • Increased competition from private equity-backed healthcare firms may impact market share.
  • Potential regulatory delays could extend restructuring timelines and increase costs.
  • Transition to a private company may reduce transparency and investor confidence.

What makes Akumin unique

  • Akumin focuses on outpatient imaging services, aligning with cost-effective healthcare trends.
  • The company integrates AI to enhance diagnostic accuracy and workflow efficiency.
  • Akumin's emphasis on value-based care aligns with industry shifts towards quality outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

Cantech Letter
Oct 23rd, 2023
Akumin likely won’t get a better offer than Stonepeak, Clarus says

The deal from private equity firm Stonepeak to acquire Akumin likely won’t be topped, says Clarus Securities analyst Noel Atkinson.

PR Newswire
Oct 20th, 2023
Akumin Inc. Reaches Agreement With Stonepeak To Become A Private Company

Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growthApprovals received from key stakeholders across capital structure; transaction will be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 daysBusiness will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary coursePLANTATION, Fla., Oct. 20, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success. The contemplated transaction will result in Akumin no longer being publicly listed.To effect the transaction in a timely and efficient manner, the Company and certain of its subsidiaries will commence prepackaged chapter 11 cases in the Southern District of Texas. The Company expects to obtain court approval of the transaction within the next 45 days and complete the transaction after receiving certain regulatory approvals. Throughout the process, Akumin's operations are expected to continue as normal